Oct 24, 2024 / 12:00PM GMT
Guido Oelkers - Swedish Orphan Biovitrum AB(publ)-President - Chief Executive Officer
Yeah, thank you so much and welcome everybody. This is Guido Oelkers CEO of SOBI, so we are delighted to welcome you to the third quarter, 2024 conference call for investors and analysts. We posted this presentation earlier today under sobi.com.
Please turn to page number two. And as per usual forward-looking statement, please take note of it and unless stated otherwise, we are making comments that most relate to the third quarter at constant exchange rate in millions of Swedish kronor.
Today, we plan to cover the key aspects of the Q3 report.
I'm joined by Henrik Stenqvist, our CFO Lydia Abad-Franch, Head of R&D and Chief Medical Officer and during the Q&A session by Armin Reininger our Senior Scientific Adviser, we plan to review the during the presentation first and then cover Q&A thereafter. And this session will take around, we'll take until 3 p.m. for those on the phone. As as usual, please join the queue for question and by pressing
Q3 2024 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript
Oct 24, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers